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MTT assayAbstract The cytotoxic effects on human lymphocytes of two gliotoxin samples (one pure sample
produced in the laboratory for this study, and one sample purchased from a standard source) were
assessed at four different concentrations (25, 50, 100 and 200 ng/ml) using the methylthiazol tetra-
zolium (MTT) bioassay. The results showed that growth was inhibited by 21, 39.10, 61.99 and
87.45% for each of the four concentrations of the pure sample, respectively, and by 17.89, 34.92,
58.34 and 85.22% respectively, in the case of the standard purchased sample. Deoxyribonucleic acid
(DNA) was extracted from the lymphocytes and analysed by electrophoresis on a 1% agarose gel.
Gliotoxin appeared to have the ability to degrade or damage the DNA. The present study showed
that both the growth inhibition and DNA damage experienced by the human lymphocytes increased
linearly with increasing concentrations of toxin.
ª 2014 TheAuthors. Production and hosting by Elsevier B.V. on behalf of King SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mycotoxins are secondary fungal metabolites which pose a
major risk to the health of humans, animals and crops (Wild
and Gong, 2010). Amongst the mycotoxins, gliotoxin is one
of the most abundant metabolites produced by Aspergillusfumigatus and some other types of fungi. Gliotoxin possesses
a wide spectrum of biological activities, which include antibac-
terial and antiviral activities, inhibiting platelet function and is
also a potent immunomodulating agent (Waring and Beaver,
1996) (Fig. 1).
In vitro, gliotoxin has been shown to be able to inhibit the
activation of antigen mediated lymphocyte stimulation, cyto-
toxic-T-cell activation, and gamma interferon production by
CD4 lymphocytes (Wichmann et al., 2002). It has also been
shown to inhibit mitogenic stimulation of human lymphocytes
(Richard et al., 1994). At higher concentrations, gliotoxin
induces apoptosis in macrophages and lymphocytes by a mech-
anism which is distinct from its antiphagocytic effects. This
toxicity against the immune system induces the apoptotic cell
Figure 1 Chemical structure of gliotoxin.
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spleen cells and other characteristic changes caused by DNA
fragmentation and adduct formation (Golden et al., 1998;
Waring and Beaver, 1996). The toxicity of gliotoxin is thought
to be mediated in at least two ways: ﬁrstly, through conjuga-
tion to proteins with susceptible thiol residues, and their sub-
sequent inactivation; secondly, through generation of
reactive oxygen species via redox cycling (Kwon-Chung and
Sugui, 2009).
An important property of gliotoxin, which has been specif-
ically identiﬁed in human lymphocyte cells following exposure
to gliotoxin, is its ability to go through a redox cycle in the
presence of an appropriate reducing agent (Waring and
Beaver, 1996). Hydrogen peroxide, as well as other reactive
oxygen species (ROS) which are produced by gliotoxin during
the redox cycle in a cell-free system is known to damage plas-
mid directly and cellular DNA (Schnabl et al., 2002).
The objective of the present study is to assess the cytotoxic
and genotoxic effects of gliotoxin puriﬁed from local A. fumig-
atus isolate and standard gliotoxin (purchased from Sigma–
Aldrich for laboratory use) on human lymphocytes in vitro
using an MTT assay.
2. Materials and methods
2.1. Extraction and puriﬁcation of gliotoxin
Gliotoxin was produced by A. fumigatus under the following
conditions: A. fumigatus was inoculated on a long grain rice
medium for 10 days at 37 C. The gliotoxin was extracted twice
with an electric homogenizer using 50 ml chloroform and ﬁl-
tered through a Whatman No. 1 ﬁlter paper. The collected ﬁl-
trate after extraction with chloroform was pooled and dried by
evaporation and stored at 4 C (Kosalec et al., 2005). The
entire dried residue was combined, and dissolved in 2 ml meth-
ylene chloride before being ﬁltered through a 0.45 lm Milli-
pore ﬁlter. The ﬁltrate was then placed on a silica gel Sep-
Pak column and primed with 5 ml of methylene chloride.
The Sep-Pak was eluted with 2 ml of hexane, ethyl acetate,
chloroform, and methanol and was then evaporated to dryness
and dissolved in 1 ml methylene chloride (Richard et al., 1989).
After puriﬁcation, the concentration was determined by Thin
Layer Chromatography (TLC) and High Performance Liquid
Chromatography (HPLC) and compared with standard glio-
toxin, which had been purchased from Sigma–Aldrich Pub-
Chem Substance ID 24895384 (molecular weight of 326.39
and produced from Gliocladium ﬁmbriatum).
The TLC plates were used for detection of the gliotoxin
with a methylene chloride: methanol (97:3 v/v) solvent systemas the mobile phase. The plates were air-dried and gliotoxin
was visualized with a spray reagent of 5% silver nitrate in eth-
anol: water (90:5 v/v).
2.2. Preparation of toxin concentration
Both standard gliotoxin and gliotoxin extract were dissolved in
methanol at 1 mg/ml and used to prepare concentrations of 25,
50, 100 and 200 ng/ml in complete culture media (RPMI-1640
medium supplemented with 10% fetal calf serum, containing a
solution of penicillin 100 units/ml and streptomycin 100 lg/ml)
(Freshney, 2012).
2.3. Collection and processing of human lymphocytes
Peripheral venous blood was taken from a healthy 26 year old
male donor and lymphocytes were extracted following Rafael
and Vaclav (2000). The suspension of cultured human lympho-
cytes was adjusted until the number of cells was about 1 · 104 -
cells/ml. 100 ll of the cell suspension was then dispensed into
each of the 96 wells of a microtiter plate to give a ﬁnal cell
count of 1000 cells/well. The plates were then incubated at
37 C in an incubator supplemented with 5% CO2 for 24 h
(Wichmann et al., 2002). After incubation, gliotoxin was added
to each well at different concentrations and incubated for 24 h
(Rafael and Vaclav, 2000).
2.4. Cytotoxicity assay using the 3-[4,5-dimethylthiazoyl]-2, 5-
diphenyltetrazolium bromide (MTT) test
This test was performed by dissolving 3-[4,5-dimethylthiazoyl]-
2, 5-diphenyltetrazolium bromide in phosphate buffered saline
(PBS) at 2 mg/ml, ﬁltrated by a 0.22 lm millipore ﬁlter. 50 ll
of the MTT dye was added to each of the microtiter plate wells
containing human lymphocytes treated with different concen-
trations of gliotoxin for 24 h. The MTT-formazan crystals,
which are formed only by live cells, were dissolved in 100 ll
Dimethyl sulphoxide (DMSO), enabling the optical density
of each well to be measured using an ELISA reader at a trans-
mitting wavelength of 620 nm (Freshney, 1994). The inhibitory
rate was measured according to Wang et al. (2003) as follows:
Growth Inhibition % ¼ O:D: of controlO:D: of Sample
O:D: of control
 1002.5. Genotoxicity assay
After the incubation period, all the treated human lymphocyte
content of the wells was transferred from the well of the micro-
titer plate by micropipette before staining to a sterile Eppen-
dorf tube for use in the genotoxicity assay. DNA was
extracted from the cultured cells using a genomic DNA mini
kit (Geneaid Company). The samples were analysed by electro-
phoresis on a 1% agarose gel, following Sambrook et al.
(1989). Visual observations of DNA were recorded with UV
camera system (Abraham et al., 2008). Statistical analysis
was performed on all the concentrations and the control with
mean ± standard error and differences between means being
performed by One Way Analysis of Variance (ANOVA)
according to SAS (2004).
Figure 3 (A) Detection of standard Gliotoxin (B) Detection of
cultured gliotoxin extract produced by A. fumigatus in rice medium
conditions using HPLC analysis: gliotoxin retention time approx-
imately 10.2 min,mobile phasemethanol: water (43:57), wavelength
254 nm, ﬂow rate was 2.0 ml/min, column length (30 cm · 4.6 mm).
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3.1. Detection of the gliotoxin by TLC and HPLC
Gliotoxin appeared brown in colour (under visible light) on
the TLC plates before spraying with silver nitrate reagent,
and yellow in colour under UV at 365 nm. After spraying with
silver nitrate, it appeared dark brown in colour under UV at
365 nm (Fig. 2). Similar results were obtained by Abu-Seidah
(2003). In the present study, different solvents were trialled
for gliotoxin puriﬁcation in a Sep-Pak column (hexane, ethyl
acetate, chloroform and methanol). The results showed that,
of these solvents, gliotoxin was only contained in the ethyl ace-
tate fractions (Fig. 2). The use of TLC to separate compounds
is based on the competition of the solute and the mobile phase
for binding places on the stationary phase. The separation of
components is measured by the retardation factor (Rf) value
or by using ﬂuorescent reagents that allow the visualization
of spots under UV–Cabinet light.
The sensitivity of TLC method is such that separations of
less than microgram amounts of material can be achieved,
while for large scale; the preparative. This technique is consid-
ered a good technique for extraction and puriﬁcation in order
to achieve a yield sufﬁcient for use in different cytotoxic stud-
ies (Al-Atby, 2001).
The gliotoxin extract was analysed against the standard
gliotoxin using HPLC analysis with a column with a length
of 30 cm · 4.6 mm, and a solvent system composed of metha-
nol/water at a ratio of 43:57 v/v. The gliotoxin extract was
revealed to be very satisfactory because it gave a single peak
at a retention time of 10.2 min, which was very similar to that
of standard gliotoxin (Fig. 3).
Analysis of a wide variety of compounds has been achieved
using HPLC, where the separation of a mixture into its compo-
nents depends on the different degrees of retention of each one
in the column. The retention time of 10.2 min observed here
differs quite markedly from that reported by Richard et al.
(1989) who used HPLC analysis with a column length of
10 cm · 4.6 mm to return a retention time of 4.8 min. This dif-
ference may be due to the difference in the length of the col-
umn that was used in the separation.Figure 2 Detection of the gliotoxin by TLC plate, St: standard
gliotoxin C: crude extract F: ﬁltered extract by millipore ﬁlters
0.45 lm, M: methylene chloride 1: hexane 2: ethyl acetate 3:
chloroform 4: methanol.3.2. Cytotoxic effects of gliotoxin on human lymphocytes
A comparison between the cytotoxic effect of different concen-
trations of the sample gliotoxin extracted from A. fumigatus
and the commercially available standard showed a signiﬁcant
difference P< 0.05, Fig. 4.
The growth inhibition observed on the growth of lympho-
cytes incubated with concentrations of 200, 100, 50 and
25 ng/ml was 87.45%, 61.99%, 39.10%, 21%, respectively,
for the sample gliotoxin and 85.22%, 58.34%, 34.92% and
17.89% for the standard gliotoxin, respectively. The results
clearly indicate that the rate of inhibition of growth was con-
centration dependent. The inhibitory effect was increased
when compared with the negative control (Fig. 4).
The active groups OH, CH3, CH2OH and an internal
bridge of gliotoxin, or any chemical compound, are responsi-
ble for their biological activity. Gliotoxin therefore can inacti-
vate proteins via a sulphide: thiol exchange and the cross
linking with proteins occurs via cysteine residues, while the del-
eterious reactive oxygen species (ROS) observed between the
reduced and oxidized form takes place through the redox
cycling (Kwon-Chung and Sugui, 2009; Collins et al., 1997).
The colorimetric cytotoxic assay by MTT is widely used for
the measurement of cell viability (Cetin and Bullerman, 2005).
The assay is dependent on the fact that the MTT dye is
reduced to a purple formazan product by live cells. The higher
the number of live cells, therefore, the more MTT-formazan is
produced. The quantity of MTT-formazan produced can be
determined spectro-photometrically once it is solubilized in a
Figure 4 Cytotoxic effect of puriﬁed gliotoxin from Aspergillus fumigatus and standard gliotoxin on human lymphocytes after a 24 h
incubation period.
Figure 5 Agarose gel electrophoresis of the DNA extracted from
human lymphocytes after being treated with different concentra-
tions of standard gliotoxin and puriﬁed gliotoxin showing degrada-
tion of lymphocyte DNA when compared with control. M: marker,
Nc: negative control, C: control, Yellow No.: concentrations of
puriﬁed gliotoxin, White No.: concentrations of standard gliotoxin.
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(Abraham et al., 2008).
Gliotoxin induces apoptosis through the elevation of the
cAMP concentration (Waring et al., 1997). Meanwhile,
Dheeb et al. (2013) have described how gliotoxin causes mor-
phological changes in normal cells due to a loss of adherence
between the cells and their plastic container, which is inher-
ently an apoptotic process. Nierman and Fedorova (2008)
have gone on to describe this phenomenon in lymphocytes,
spleen cells, thymocytes and macrophages.
Richard et al. (1994) investigated the cytotoxic and immu-
nosuppressive effects of gliotoxin in turkey lymphocytes via a
conversion of salt MTT to MTT formazan by the mitochon-
drial succinate dehydrogenase in living cells (Richard et al.,
1994). They concluded that all lymphocyte cells appeared to
be dead when they were exposed to gliotoxin at a concentra-
tion of 100 ng/ml, but that little or no response was evident
below 100 ng/ml. The level of cytotoxicity in the lymphocyte
proliferation assay was correlated with that demonstrated in
the MTT test. McMinn et al. (1991), on the other hand, using
a murine model, observed a reduction in the number of Lan-
gerhans cells as well as ultrastructural damage even when glio-
toxin concentrations in comparison with control were lower
than 100 ng/ml. Furthermore, they noted that, at lower con-
centrations, the toxin appeared to stimulate a proliferation
response and increase the conversion of the salt to MTT for-
mazan using mice and turkey lymphocytes.
Sutton et al. (1995) also used lymphocytes frommice to study
the effect of gliotoxin. Their results showed that gliotoxin has
potential clinical applications as an immunosuppressive agent
in preventing allograft rejection. At low doses (<30 nM) glio-
toxin displays co-mitogenic activity, and decreases intracellular
cAMP levels, but at higher concentrations it induces apoptosis
in cells and increases intracellular cAMP levels. The effects of
gliotoxin on cell activation and the induction of apoptosis,
therefore, may both be mediated by changed levels of cAMP.
Dheeb et al. (2013) studied the in vitro effects of different
concentrations (0.12–125 ng/ml) of gliotoxin on the growth
of the human hepatocellular carcinoma HepG2 cell line. Their
results indicated that the rate of growth inhibition was concen-
tration dependent. Ben-Ami et al. (2009) show that gliotoxinaffects platelet function and inhibits angiogenesis in vitro at
concentrations ranging from 30 to 3000 ng/ml.
Two of the properties of gliotoxin that might assist A.
fumigatus in the colonization of the respiratory mucosa are
that it causes damage to the ciliated respiratory epithelium
and that it inhibits the oxidative burst of human neutrophils
in vitro (Nierman and Fedorova, 2008).
3.3. Genotoxic effects of gliotoxin on human lymphocytes
DNA was extracted from lymphocytes treated with 200, 100,
50 and 25 ng/ml concentrations of gliotoxin and then analysed
by electrophoresis on a 1% agarose gel. The gliotoxin
appeared to have the ability to degrade or damage the DNA
with the extent of damage increasing gradually as the concen-
tration of gliotoxin increased (Fig. 5).
The known biological properties of gliotoxin include the
capability to undergo redox cycling to generate oxygen free rad-
icals that cause oxidative damage to isolated DNA in vitro
(Eichner et al., 1988). This toxicity against the immune system
induces apoptotic cell death of thymocytes, peripheral lympho-
cytes, macrophages, spleen cells and other characteristics, for
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et al., 1998). Gliotoxin is involved with a number of proteins in
the formation of disulphide bridges (Gardiner and Howlett,
2005). This toxicity is thought to be mediated in at least two
ways. First, conjugation to proteins with susceptible thiol resi-
dues and subsequent inactivation, second, generation of reactive
oxygen species via redox cycling (Kwon-Chung and Sugui,
2009). Also, the DNA-reactivity of gliotoxin has been investi-
gated in some in vitro studies (Golden et al., 1998), which dem-
onstrate that the reactive oxygen species produced by gliotoxin
are capable of evoking DNA damage. This damage in DNA in
cells treatedwith gliotoxin was observed at 24 h.Higher concen-
trations of gliotoxin (0.8–1.6 lg/ml), are toxic to the cells
(Nieminen et al., 2002).
4. Conclusions
1. The sample gliotoxin shows a higher cytotoxic effect than
standard gliotoxin.
2. The inhibition % in the growth of human lymphocytes
increased with an increase in gliotoxin concentration.
3. Gliotoxin showed high genotoxic effects, even at low con-
centrations and DNA damage increased with an increase
in gliotoxin concentration.
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